Frederic G Barr

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Mesenchymal Stem Cells

Gene Expression

Genome Wide Association Study

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kay Nakazawa, Taryn Shaw, Young K Song, Marilyn Kouassi-Brou, Anna Molotkova, Purushottam B Tiwari, Hsien-Chao Chou, Xinyu Wen, Jun S Wei, Emre Deniz, Jeffrey A Toretsky, Charles Keller, Frederic G Barr, Javed Khan, Aykut Üren
Piperacetazine directly binds to the PAX3::FOXO1 fusion protein and inhibits its transcriptional activity. Cancer research communications (2023)
Zhongqiu Xie, Pawel L Janczyk, Xinrui Shi, Qiong Wang, Sandeep Singh, Robert Cornelison, Jingjing Xu, James W Mandell, Frederic G Barr, Hui Li
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL. Proceedings of the National Academy of Sciences of the United States of America 119 (24) (2022)
Zhongqiu Xie, Pawel L Janczyk, Xinrui Shi, Qiong Wang, Sandeep Singh, Robert Cornelison, Jingjing Xu, James W Mandell, Frederic G Barr, Hui Li
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL. Proceedings of the National Academy of Sciences of the United States of America 119 (24) (2022)
Zhongqiu Xie, Pawel L Janczyk, Xinrui Shi, Qiong Wang, Sandeep Singh, Robert Cornelison, Jingjing Xu, James W Mandell, Frederic G Barr, Hui Li
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL. Proceedings of the National Academy of Sciences of the United States of America 119 (24) (2022)
Zhongqiu Xie, Pawel L Janczyk, Xinrui Shi, Qiong Wang, Sandeep Singh, Robert Cornelison, Jingjing Xu, James W Mandell, Frederic G Barr, Hui Li
Rhabdomyosarcomas are oncogene addicted to the activation of AVIL. Proceedings of the National Academy of Sciences of the United States of America 119 (24) (2022)
Katie E Hebron, Xiaolin Wan, Jacob S Roth, David J Liewehr, Nancy E Sealover, William J E Frye, Angela Kim, Stacey Stauffer, Olivia L Perkins, Wenyue Sun, Kristine A Isanogle, Christina M Robinson, Amy James, Parirokh Awasthi, Priya Shankarappa, Xiaoling Luo, Haiyan Lei, Donna Butcher, Roberta Smith, Elijah F Edmondson, Jin-Qiu Chen, Noemi Kedei, Cody J Peer, Jack F Shern, William Douglas Figg, Lu Chen, Matthew D Hall, Simone Difilippantonio, Frederic G Barr, Robert L Kortum, Robert W Robey, Angelina V Vaseva, Javed Khan, Marielle E Yohe
The combination of trametinib and ganitumab is effective in RAS-mutated PAX-fusion negative rhabdomyosarcoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)